Research by Goal
Explore preclinical research on peptides and bioactive compounds grouped by research goal. Each page covers the studied compounds, mechanisms, and current evidence for that application.
Gut Healing
Your gut lining replaces itself every few days — a remarkable feat of biological engineering. But when damage outpaces repair, this barrier weakens. BPC-157 was discovered in human gastric juice precisely because it appears to play a fundamental role in this repair process [PMID: 25529739]. Unlike synthetic compounds designed in a lab, BPC-157 is derived from a protein your body already produces in the very environment where gut healing matters most.
Tendon Repair
Tendons have a problem: they need to withstand enormous force, yet they receive very little blood flow. This poor vascularization is why tendon injuries heal slowly and often incompletely [PMID: 30578978]. Two mechanistically distinct peptides — BPC-157 and TB-500 — are being researched for their potential to address tendon repair from different but complementary angles.
Wound Healing
What if the breakthrough in wound healing isn't a single molecule but the recognition that wounds need simultaneous solutions across multiple biological layers? Three entirely different peptides offer complementary approaches: BPC-157 amplifies growth signaling through mTOR and nitric oxide pathways [PMID: 25529739]; TB-500 reorganizes cellular architecture and builds new blood vessels [PMID: 18493016]; GHK-Cu directly stimulates the structural proteins damaged tissue needs [PMID: 22512572]. This is not redundancy — it's the recognition that wound healing is fundamentally a multi-system problem.
Injury Recovery
Here's a question most injury conversations skip: why does some tissue heal while structurally similar tissue doesn't? The difference isn't luck — it's whether the biological repair machinery receives the right signals at the right time. BPC-157 and TB-500 approach this problem from opposite but complementary directions. BPC-157 research suggests it amplifies the cellular growth cascade through mTOR and nitric oxide pathways [PMID: 25529739]. TB-500 studies indicate it builds the vascular and structural scaffolding that regenerating tissue desperately requires [PMID: 18493016]. Understanding both reveals why researchers explore them not as competitors but as potential sequential partners in recovery.
Skin Health
Your skin contains a repair mechanism that operates less efficiently with each passing year. That decline has a name: declining levels of GHK-Cu, a naturally occurring copper peptide found in human plasma, saliva, and wound fluid [PMID: 22512572]. Research suggests this endogenous compound may reactivate the biological machinery responsible for collagen synthesis, antioxidant defense, and tissue remodeling — processes that slow dramatically as chronological age advances. What makes GHK-Cu unusual in peptide research is that the question isn't whether a foreign molecule helps, but whether restoring an endogenous molecule that declines with age can reverse certain aging phenotypes at the tissue level.
Anti-Aging
Aging is not a single biological event — it is a constellation of parallel declines across multiple systems. Two distinct research pathways dominate the anti-aging peptide conversation, and they address fundamentally different layers of the problem. GHK-Cu acts locally on skin fibroblasts to support collagen synthesis and antioxidant defense — targeting the visible structural changes that accompany chronological aging [PMID: 22512572]. CJC-1295 and Ipamorelin operate systemically on the growth hormone (GH) axis, addressing the hormonal decline known as somatopause, where GH secretion drops roughly 30–50% by age 60 [PMID: 16352683]. Understanding where each pathway operates — local versus systemic — is the key to understanding why researchers explore them separately and, occasionally, in combination.
Muscle Growth
Most people assume growth hormone builds muscle directly. Here’s the biological plot twist: it doesn’t — GH signals the liver to produce IGF-1, which then acts on muscle tissue itself [PMID: 16352683]. This two-step relay system is what makes CJC-1295 and Ipamorelin such a frequently paired combination in muscle research conversations. Understanding the chain is essential before evaluating the individual compounds.
Fat Loss
Growth hormone does something unusual: it mobilizes stored fat while simultaneously driving anabolic processes in muscle [PMID: 16352683]. This creates a metabolic state rarely achieved by other compounds — tissues are being asked to build and burn at the same time. Understanding this paradox is the starting point for evaluating CJC-1295 and Ipamorelin in fat-loss research.
Weight Loss
Most weight-loss conversations in 2026 center on GLP-1 receptor agonists. But there is a separate metabolic pathway worth understanding: growth hormone signaling, which influences body composition through lipolysis rather than appetite suppression [PMID: 16352683]. CJC-1295 and Ipamorelin sit at the center of this alternative mechanism — one that works on fat cells themselves rather than on hunger signals in the brain.
Joint Pain
Joint pain sits at the intersection of inflammation, tissue damage, and repair capacity — and peptides approach this complexity from completely different angles. BPC-157 was discovered in gastric fluid but shows remarkable effects on tendon and ligament healing [PMID: 25529739], while TB-500 governs the structural scaffolding that cells use to migrate and rebuild. Understanding their distinct mechanisms is essential before evaluating them together.
Sleep
Growth hormone secretion peaks during deep sleep — and certain GH secretagogues may influence this natural rhythm. Research suggests a bidirectional relationship between GH release and sleep architecture [PMID: 16352683], raising the question of whether peptides that modulate the GH axis could also influence sleep quality.
Longevity
Longevity research increasingly recognizes that aging is not one problem but many — and effective interventions must address multiple layers simultaneously. Three peptides offer distinct mechanisms that target aging at different biological levels [PMID: 22512572] [PMID: 16352683]. GHK-Cu works at the cellular level, supporting collagen synthesis and antioxidant defense. CJC-1295 and Ipamorelin operate systemically on the growth hormone axis, addressing the hormonal decline of aging. Together, they represent a multi-target approach to age-related decline.
Inflammation
Inflammation is the body's alarm system — essential when activated briefly, destructive when it never shuts off. Peptide research is uncovering new ways to modulate inflammatory cascades at specific checkpoints rather than blunting them entirely. BPC-157 and TB-500 approach inflammation through distinct molecular mechanisms, offering researchers two different tools for understanding immune signaling.
Recovery
Recovery is not the absence of training — it's an active biological process of repair and adaptation. BPC-157 and TB-500 approach this process from different but complementary directions [PMID: 30578978] [PMID: 22726581]. BPC-157 research suggests it amplifies the cellular growth cascade, while TB-500 builds the vascular and structural infrastructure that regenerating tissue requires. Understanding both reveals why researchers explore them as complementary tools in recovery research.
Brain Health
The brain depends on a delicate balance of neurotransmitter signaling, antioxidant defense, and neuronal repair. When this balance tips toward inflammation or oxidative stress, cognitive function can decline in ways researchers are working to understand [PMID: 25529739]. Two peptides — BPC-157 and GHK-Cu — are being studied for their potential to support brain health through entirely different mechanisms.
Immune Support
The immune system is a distributed network of cells and signals that must balance vigilance with restraint — attacking threats while sparing healthy tissue. TB-500 and GHK-Cu approach immune support from fundamentally different angles [PMID: 22726581] [PMID: 22512572]. TB-500 influences immune cell migration and inflammatory resolution, while GHK-Cu supports the antioxidant defenses that protect immune cells during activation.
All research on this site is preclinical unless otherwise noted. Evidence comes from animal models and in vitro studies. None of this constitutes medical advice.